Veracyte
VCYT
48 hedge funds and large institutions have $69.3M invested in Veracyte in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 48 → 48 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
24% less capital invested
Capital invested by funds: $91.2M → $69.3M (-$21.9M)
Top Buyers
Top Sellers
VCYT Hedge Fund Activity: Q1 2015 in Review
48 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2015, worth a combined $69.3M — down 24% from $91.2M a quarter earlier.
Fund positioning in VCYT was balanced in Q1 2015: 5 funds opened new positions, 5 closed out, 13 added to existing stakes and 13 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $1.93M. The largest seller was Great Point Partners, cutting an estimated $3.98M.
- 48 institutional investors held Veracyte (VCYT) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $69.3M of Veracyte stock for Q1 2015, down 24% quarter-over-quarter.
- 5 funds opened new Veracyte positions in Q1 2015 and 5 closed out, a net change of 0 holders.
- The largest Veracyte buyer in Q1 2015 was Consonance Capital Management, an estimated $1.93M added.
- The largest Veracyte seller in Q1 2015 was Great Point Partners, an estimated $3.98M sold.
Based on aggregated 13F filings for Q1 2015.